Company / Current Assets per Share
Celldex Therapeutics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$8.03
FY2025
5-year range
$6.73 / $11.26
FY2021-FY2025
Trend
-28.6%
vs FY2024
Sector context
#105 of 159
Health Care
What the data says
At $8.03, Celldex Therapeutics, Inc.'s current assets per share ranks #105 of 159 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $1.20 in FY2017 to $11.26 in FY2024.
Based on SEC 10-K filings.
8.03 in FY2025 with a 5-year CAGR of +10.0%.
Improved from $7.72 to $8.03 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +6.1%
- 5-Year CAGR
- +10.0%
- 10-Year CAGR
- -
Sector benchmark
#105 of 159 in Health CareTop 66% of 159This company $8.03 Sector average $54.15
▼
-85.2% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 28.6% year-over-year.
- Ranks #105 out of 159 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2024.
- Lowest current assets per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.40 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.03 | -28.6% |
| FY2024 | $11.26 | +45.7% |
| FY2023 | $7.72 | +14.8% |
| FY2022 | $6.73 | -23.4% |
| FY2021 | $8.79 | +76.0% |
| FY2020 | $5.00 | +27.1% |
| FY2019 | $3.93 | -63.4% |
| FY2018 | $10.73 | +793.2% |
| FY2017 | $1.20 | -26.0% |
| FY2016 | $1.62 | -45.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026